Skip to main content
. 2023 Jan 21;21:40. doi: 10.1186/s12967-022-03860-3

Table 1.

Patient and tumour characteristics for trainning cohort

TFC (n = 15) PCa (n = 15) CRPC (n = 15)
Age (years)
 Median (range) 54 (50–75) 73.5 (52–87) 75 (66–82)
Baseline PSA (ng/ml)
 Median (range) 8.6 (0.004–167) 23.04 (0.36–100)
Local treatment, n (%)
 Endocrinotherapy 10 (67%) 11 (73%)